Holen Sie sich die Stockscreener-App
116.13
1.51%
-1.785
Handel nachbörslich:
116.13
Schlusskurs vom Vortag:
$117.92
Offen:
$118.08
24-Stunden-Volumen:
478.49K
Relative Volume:
0.87
Marktkapitalisierung:
$3.82B
Einnahmen:
$787.85M
Nettoeinkommen (Verlust:
$-27.78M
KGV:
-133.85
EPS:
-0.8676
Netto-Cashflow:
$18.75M
1W Leistung:
-8.18%
1M Leistung:
+1.92%
6M Leistung:
-35.28%
1J Leistung:
-13.79%
1-Tages-Spanne:
$114.47
$118.08
1-Wochen-Bereich:
$114.47
$129.89
52-Wochen-Spanne:
$100.85
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Holdings Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
116.13 | 3.82B | 787.85M | -27.78M | 18.75M | -0.8676 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-09-23 | Eingeleitet | Evercore ISI | In-line |
| 2025-08-20 | Eingeleitet | BofA Securities | Buy |
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Holdings Inc Aktie (IRTC) Neueste Nachrichten
Tax-related share sale by iRhythm (IRTC) EVP after RSU vesting - Stock Titan
iRhythm (IRTC) chief medical officer sells 1,423 shares for RSU tax withholding - Stock Titan
IRhythm Holdings, Inc. (IRTC) Stock Analysis: A 41% Potential Upside Beckons Investors - DirectorsTalk Interviews
Does iRhythm (IRTC) Balancing a Revenue Beat With In-Line Guidance Recast Its AI Cardiac Story? - Sahm
iRhythm Holdings, Inc. (IRTC) reports Q1 loss, tops revenue estimates - MSN
Q1 Earnings Roundup: iRhythm (NASDAQ:IRTC) And The Rest Of The Patient Monitoring Segment - Yahoo Finance
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm - Sahm
iRhythm (IRTC) Q1 2026 Earnings: EPS Beats Expectations by 47% Despite Continued LossPost-Earnings Drift - dars.gov.et
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling A Promising 50% Upside Potential - DirectorsTalk Interviews
Why iRhythm Holdings (IRTC) Is Up 10.8% After Strong Results and New DOJ InquiryAnd What's Next - Sahm
Enterprise value to EBITDA forward of iRhythm Holdings, Inc. – NASDAQ:IRTC - TradingView
I25 Forecast — Price Target — Prediction for 2027 - TradingView
iRhythm Holdings, Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Q1 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
Enterprise value to revenue forward of iRhythm Holdings, Inc. – NASDAQ:IRTC - TradingView
IRTC Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of iRhythm Holdings, Inc. – NASDAQ:IRTC - TradingView
Price to book forward of iRhythm Holdings, Inc. – NASDAQ:IRTC - TradingView
Price to sales forward of iRhythm Holdings, Inc. – DUS:I25 - TradingView
Price to earnings forward of iRhythm Holdings, Inc. – DUS:I25 - TradingView
iRhythm Holdings, Inc. Actuals & Estimates (NASDAQ:IRTC) - TradingView
iRhythm Holdings (IRTC) Dropped Despite Posting Beat-And-Raise Results - Yahoo Finance
IRTC Reiterated by BTIG -- Price Target Maintained at $185 - GuruFocus
iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a 70.98% Potential Upside for Astute Investors - DirectorsTalk Interviews
Top 3 health care stocks you'll regret missing in Q2 - MSN
iRhythm Holdings (IRTC) Advances on Positive Momentum: Key Levels to WatchMonthly Profile - dars.gov.et
Heart Monitoring Device Manufacturer Discloses Cyberattack; Data Breach - The HIPAA Journal
Top 3 Health Care Stocks You'll Regret Missing In Q2 - Benzinga
iRhythm Technologies Inc (IRTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Hackers demand payment for stolen data tied to heart monitoring company iRhythm - The Business Journals
iRhythm Technologies Inc (IRTC) Institutional Confidence - TradingKey
iRhythm discloses data breach after hackers steal patient health information and demand ransom - teiss
iRhythm Hit by Cyberattack, Patient Data Stolen and Ransom Demanded - Security Affairs
iRhythm investigates cyber incident after hackers claim access to sensitive data - MSN
iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive DataiRhythm Holdings (NASD - Benzinga
iRhythm says no impact from cybersecurity incident - MSN
iRhythm discloses cybersecurity incident (IRTC:NASDAQ) - Seeking Alpha
iRhythm Holdings, Inc. 8-K SEC Filing June 2026 – Company Details, Address, and Stock Information - Minichart
iRhythm discloses cyber incident, says no impact on device systems, patient safety - Reuters
Cyberattack at iRhythm (NASDAQ: IRTC) involves PHI but no system outage - Stock Titan
iRhythm Holdings (IRTC) Hovers Near Resistance as Consolidation ContinuesGamma Squeeze - newsline.com
IRTC Q1 2026 Earnings: EPS Surprise of 47.13% Beats ExpectationsROA Comparison - newsline.com
iRhythm Holdings (IRTC) Grinds Higher as Stock Holds Above Key Support LevelCalendar Spread Trade - newsline.com
IRTC Q1 2026 Earnings: Strong EPS Beat Amidst Absent Revenue DisclosureMargin Expansion Trends - newsline.com
Why iRhythm Holdings, Inc. (IRTC) is a top momentum stock for the long term - MSN
iRhythm Holdings (IRTC) Slides 1.08% as Support Levels Come into FocusStock Picks - newsline.com
How iRhythm’s Governance Overhaul and Shelf Registration Could Reshape the Risk Profile for IRTC Investors - simplywall.st
iRhythm Holdings, Inc. (IRTC) Stock Analysis: Navigating a 65% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
iRhythm Holdings (IRTC) Edges Higher as Stock Tests Key Resistance ZoneEqual Weight ETF - newsline.com
IRTC Q1 2026 Earnings: EPS Beats Estimates by Wide Margin but Revenue Not ReportedEarnings Weakness Phase - newsline.com
Finanzdaten der Irhythm Holdings Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):